BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Letoha T, Somlai C, Takács T, Szabolcs A, Jármay K, Jr ZR, Hegyi P, Varga I, Kaszaki J, Krizbai I, Boros I, Duda E, Kusz E, Penke B. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol 2005; 11(7): 990-999 [PMID: 15742402 DOI: 10.3748/wjg.v11.i7.990] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Arepalli SK, Choi M, Jung J, Lee H. Novel NF-κB inhibitors: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 2014;25:319-34. [DOI: 10.1517/13543776.2014.998199] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
2 Qin ZH, Tao LY, Chen X. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. Acta Pharmacol Sin 2007;28:1859-72. [PMID: 18031598 DOI: 10.1111/j.1745-7254.2007.00741.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
3 Bidwell GL, Raucher D. Therapeutic peptides for cancer therapy. Part I – peptide inhibitors of signal transduction cascades. Expert Opinion on Drug Delivery 2009;6:1033-47. [DOI: 10.1517/17425240903143745] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
4 Haydar D, Cory TJ, Birket SE, Murphy BS, Pennypacker KR, Sinai AP, Feola DJ. Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways. J Immunol 2019;203:1021-30. [PMID: 31263039 DOI: 10.4049/jimmunol.1801228] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
5 Wang Y, Liu W, Liu X, Sheng M, Pei Y, Lei R, Zhang S, Tao R. Role of liver in modulating the release of inflammatory cytokines involved in lung and multiple organ dysfunction in severe acute pancreatitis. Cell Biochem Biophys. 2015;71:765-776. [PMID: 25260395 DOI: 10.1007/s12013-014-0261-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
6 Mallavia B, Recio C, Oguiza A, Ortiz-Muñoz G, Lazaro I, Lopez-Parra V, Lopez-Franco O, Schindler S, Depping R, Egido J, Gomez-Guerrero C. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis. Am J Pathol 2013;182:1910-21. [PMID: 23597852 DOI: 10.1016/j.ajpath.2013.01.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
7 Durand JK, Baldwin AS. Targeting IKK and NF-κB for Therapy. Adv Protein Chem Struct Biol 2017;107:77-115. [PMID: 28215229 DOI: 10.1016/bs.apcsb.2016.11.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
8 Aylsworth A, Jiang SX, Desbois A, Hou ST. Characterization of the role of full-length CRMP3 and its calpain-cleaved product in inhibiting microtubule polymerization and neurite outgrowth. Exp Cell Res 2009;315:2856-68. [PMID: 19559021 DOI: 10.1016/j.yexcr.2009.06.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lin TH, Pajarinen J, Lu L, Nabeshima A, Cordova LA, Yao Z, Goodman SB. NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases. Adv Protein Chem Struct Biol 2017;107:117-54. [PMID: 28215222 DOI: 10.1016/bs.apcsb.2016.11.002] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 9.7] [Reference Citation Analysis]
10 Letoha T, Kusz E, Pápai G, Szabolcs A, Kaszaki J, Varga I, Takács T, Penke B, Duda E. In vitro and in vivo nuclear factor-kappaB inhibitory effects of the cell-penetrating penetratin peptide. Mol Pharmacol 2006;69:2027-36. [PMID: 16505157 DOI: 10.1124/mol.105.019653] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
11 Tsang SW, Guan YF, Wang J, Bian ZX, Zhang HJ. Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Sci Rep 2016;6:22859. [PMID: 26971398 DOI: 10.1038/srep22859] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
12 Zhang XP, Wu CJ, Li ZJ. Advances in research of severe acute pancreatitis complicated by lung injury. Shijie Huaren Xiaohua Zazhi 2008; 16(3): 299-306 [DOI: 10.11569/wcjd.v16.i3.299] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Letoha T, Somlai C, Takács T, Szabolcs A, Rakonczay Z, Jármay K, Szalontai T, Varga I, Kaszaki J, Boros I. The proteasome inhibitor MG132 protects against acute pancreatitis. Free Radic Biol Med. 2005;39:1142-1151. [PMID: 16214030 DOI: 10.1016/j.freeradbiomed.2005.06.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
14 Szabolcs A, Biczó G, Rakonczay Z, Tiszlavicz L, Halm G, Wittmann T, Takács T. Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitis. European Journal of Pharmacology 2009;616:270-4. [DOI: 10.1016/j.ejphar.2009.05.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
15 Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J Gastroenterol 2010; 16(32): 3995-4002 [PMID: 20731012 DOI: 10.3748/wjg.v16.i32.3995] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
16 Gilmore TD, Garbati MR. Inhibition of NF-κB signaling as a strategy in disease therapy. Curr Top Microbiol Immunol 2011;349:245-63. [PMID: 21113699 DOI: 10.1007/82_2010_105] [Cited by in Crossref: 22] [Cited by in F6Publishing: 49] [Article Influence: 2.0] [Reference Citation Analysis]
17 Szabolcs A, Varga IS, Varga C, Berkó A, Kaszaki J, Letoha T, Tiszlavicz L, Sári R, Lonovics J, Takács T. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis. Eur J Pharmacol. 2006;532:187-193. [PMID: 16499907 DOI: 10.1016/j.ejphar.2006.01.055] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
18 El-Ansary A, Bhat RS, Al-Daihan S, Al Dbass AM. The neurotoxic effects of ampicillin-associated gut bacterial imbalances compared to those of orally administered propionic acid in the etiology of persistent autistic features in rat pups: effects of various dietary regimens. Gut Pathog 2015;7:7. [PMID: 25852770 DOI: 10.1186/s13099-015-0054-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta. 2010;1799:775-787. [PMID: 20493977 DOI: 10.1016/j.bbagrm.2010.05.004] [Cited by in Crossref: 489] [Cited by in F6Publishing: 470] [Article Influence: 40.8] [Reference Citation Analysis]
20 Rivers JR, Badiei A, Bhatia M. Hydrogen sulfide as a therapeutic target for inflammation. Expert Opinion on Therapeutic Targets 2012;16:439-49. [DOI: 10.1517/14728222.2012.673591] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
21 Yi H, Peng R, Zhang LY, Sun Y, Peng HM, Liu HD, Yu LJ, Li AL, Zhang YJ, Jiang WH, Zhang Z. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell Death Dis 2017;8:e2583. [PMID: 28151474 DOI: 10.1038/cddis.2016.451] [Cited by in Crossref: 111] [Cited by in F6Publishing: 118] [Article Influence: 22.2] [Reference Citation Analysis]
22 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2005; 13(21): 2615-2619 [DOI: 10.11569/wcjd.v13.i21.2615] [Reference Citation Analysis]
23 Jones AT, Sayers EJ. Cell entry of cell penetrating peptides: tales of tails wagging dogs. Journal of Controlled Release 2012;161:582-91. [DOI: 10.1016/j.jconrel.2012.04.003] [Cited by in Crossref: 176] [Cited by in F6Publishing: 167] [Article Influence: 17.6] [Reference Citation Analysis]
24 Szabolcs A, Tiszlavicz L, Kaszaki J, Pósa A, Berkó A, Varga IS, Boros I, Szüts V, Lonovics J, Takács T. Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology. Pancreas 2007;35:249-55. [PMID: 17895846 DOI: 10.1097/mpa.0b013e318070d791] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
25 Orange JS, May MJ. Cell penetrating peptide inhibitors of nuclear factor-kappa B. Cell Mol Life Sci 2008;65:3564-91. [PMID: 18668204 DOI: 10.1007/s00018-008-8222-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
26 Letoha T, Fehér LZ, Pecze L, Somlai C, Varga I, Kaszaki J, Tóth G, Vizler C, Tiszlavicz L, Takács T. Therapeutic proteasome inhibition in experimental acute pancreatitis. World J Gastroenterol 2007; 13(33): 4452-4457 [PMID: 17724800 DOI: 10.3748/wjg.v13.i33.4452] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]